Does Rallies show 13F holders for MMSI?

Yes. Rallies tracks hedge fund and 13F ownership data for MMSI, including fund names, share counts, latest tracked quarter, and position changes when available.

Is MMSI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MMSI. It does not provide personalized investment advice.

MMSI (Merit Medical Systems Inc) Stock Analysis - Hedge Fund Holdings

Merit Medical Systems Inc (MMSI) is a publicly traded Healthcare sector company. As of May 21, 2026, MMSI trades at $64.61 with a market cap of $3.80B and a P/E ratio of 29.58. MMSI moved +1.13% today. Year to date, MMSI is -27.88%; over the trailing twelve months it is -34.73%. Its 52-week range spans $59.74 to $111.45. Analyst consensus is strong buy with an average price target of $87.50. Rallies surfaces MMSI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns MMSI stock?

Hedge funds tracked by Rallies that own MMSI include Maverick Capital, Soros Fund, Panagora Asset, Bridgewater Associates, and Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Merit Medical Systems Inc.

MMSI Key Metrics

Key financial metrics for MMSI
Metric	Value
Price	$64.61
Market Cap	$3.80B
P/E Ratio	29.58
EPS	$2.17
Dividend Yield	0.00%
52-Week High	$111.45
52-Week Low	$59.74
Volume	19
Avg Volume	0
Revenue (TTM)	$1.52B
Net Income	$128.49M
Gross Margin	48.70%

Top Hedge Funds Holding MMSI

Maverick Capital holds 714.08K shares of MMSI, changed +46.88% as of Mar 31, 2026.
Soros Fund holds 76.20K shares of MMSI, changed +0.00% as of Dec 31, 2023.
Panagora Asset holds 55.85K shares of MMSI, changed +1.71% as of Mar 31, 2026.
Bridgewater Associates holds 5.51K shares of MMSI, changed +125.70% as of Mar 31, 2026.
Farallon Capital holds 3.00K shares of MMSI, changed +0.00% as of Mar 31, 2026.

Latest MMSI News

Merit Medical Q1 Net Income Hits $56.7M, Viewpoint Deal Triples Oncology Market — May 1, 2026
Merit Medical Q1 Revenue Up 7%, GAAP EPS Jumps 39% and Acquires OneMark for $140M — Apr 30, 2026
Merit Medical Acquires View Point Medical for $140M to Expand Oncology Portfolio — Apr 2, 2026
Merit Medical Launches Resilience TTS Esophageal Stent in Three Sizes with Anti-Migration Flanges — Mar 16, 2026
Merit Medical's Forward P/E of 19.05 Beats Straumann's 29.03 — Mar 2, 2026

Recent MMSI Insider Trades

Smith Christian Adam bought 1.63K (~$99.19K) on May 11, 2026.
Ward Lynne N. sold 5.00K (~$313.04K) on May 7, 2026.
Lloyd Brian G. bought 2.00K (~$125.25K) on May 7, 2026.

MMSI Analyst Consensus

10 analysts cover MMSI: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $87.50.

Common questions about MMSI

Who owns MMSI stock?: Hedge funds tracked by Rallies that own MMSI include Maverick Capital, Soros Fund, Panagora Asset, Bridgewater Associates, and Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Merit Medical Systems Inc.
Does Rallies show 13F holders for MMSI?: Yes. Rallies tracks hedge fund and 13F ownership data for MMSI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is MMSI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MMSI. It does not provide personalized investment advice.